Advertisement
Table 1 Patient characteristics
| Characteristics | N = 20 |
|---|---|
| Epidemiology | |
| Age, y, mean ± SD | 31 ± 8 |
| Female gender, n (%) | 20 (100) |
| Previous SLE manifestations | |
| Skin, n (%) | 11 (55) |
| Joints, n (%) | 9 (45) |
| Serositis, n (%) | 4 (20) |
| Kidney, n (%) | 11 (55) |
| Central nervous system, n (%) | 1 (5) |
| SELENA-SLEDAI at Day 0, mean (range) | 2 (0 to 8) |
| 25-Hydroxyvitamin D levels | |
| Mean ± SD, ng/mL | 22 ± 11 |
| 25(OH)D ≤ 10 ng/mL, n (%) | 1 (5) |
| 11 < 25(OH)D ≤ 20 ng/mL, n (%) | 11 (55) |
| 21 < 25(OH)D ≤ 30 ng/mL, n (%) | 8 (40) |
| Associated treatments* | |
| Prednisone, n (%) | 14 (70) |
| Prednisone, median, mg/day (range) | 5 (0 to 15) |
| Hydroxychloroquine, n (%) | 17 (85) |
| Azathioprine, n (%) | 2 (10) |
| Mycophenolate mofetil, n (%) | 1 (5) |
